China’s Patent Law Move Towards Enabling Innovation in Biotech
shot by IP News Shots / 5:03 pm on 04 May, 2021
China has worked on the revision of their Patent Law to make it more favorable for biotech innovation and for encouraging more foreign drugs to enter the market in the country. The revised law establishes a drug patent linkage system and compensates for lost patent terms, on the lines of the Hatch-Waxman Act in the US. The new version of the Patent Law is set to be put to action from the 1st of June, 2021.
Read More at: https://www.bioworld.com/articles/506664-china-overhauls-patent-law-to-stay-competitive-in-biotech-innovation?v=preview
Industry: Biotechnology | Type of IP: Regulations